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WS12.5 Lung clearance index and exercise capacity among children
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Objectives: To compare FEV1, LCI and exercise capacity among children with CF
and non-CF bronchiectasis and healthy controls.
Methods: Eighteen stable children and adolescents with CF, 15 stable children
with non-CF bronchiectasis and 20 healthy children and adolescents were requited.
Spirometry and multiple-breath-washout tests were performed. All children per-
formed a cardiopulmonary exercise test on cycle ergometer. Children with CF and
non-CF bronchiectasis had a HRCT scan, which was evaluated using the modiﬁed
Bhalla score.
Results: The patients’ mean age was 14.7 years, mean FEV1 75.8% predicted,
while the healthy children’s mean age was 14.9 years, mean FEV1 98.9%. Total
Bhala score and FEV1 did not differ signiﬁcantly among children with CF and
non-CF bronchiectasis (p> 0.05). Mean VOpeak was signiﬁcantly impaired among
children with bronchiectasis compared to healthy children (p< 0.01), but did not
differ signiﬁcantly among children with CF and non-CF bronchiectasis (p: 0.225).
Patients with CF bronhiectasis had signiﬁcantly higher respiratory equivalent to
carbon dioxide (VE/VCO2) and higher physiologic dead space to tidal volume
ratio (VD/VT), during exercise, compared to non-CF patients (p< 0.001). LCI
was signiﬁcantly increased among patients with bronchiectasis compared to healthy
children (p< 0.01). LCI did not differ signiﬁcantly among children with CF and
non-CF bronchiectasis (p: 0.22).
Conclusions: Exercise testing and Multiple Breath Washout measurements can
discriminate children with mild bronchiecatsis from healthy children. However, the
burden of the disease is more prominent in children with CF compared with the
non-CF bronchiectasis.
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Background: Bronchiectasis (BE) detected by chest CT in young children is an
important outcome measure for clinical studies. For these studies it is important to
use objective, sensitive and reproducible methods to detect and monitor progression
of BE.
Aim: To compare sensitivity of two methods to detect BE on chest CTs in young
CF patients.
Methods: Routine chest CTs of 10 patients aged 2 years were randomly selected
from the Sophia Children’s Hospital and of 10 patients aged 3 years from the
Princess Margaret Hospital for Children. In addition the follow up chest CTs of
these children 2 years later (age 4 and 5 years) were selected. CTs were randomized
and de-identiﬁed (Myrian, Intrasense, France). BE was scored using the CF-CT
scoring module in all scans. In the same batch, all airway-artery (AA) pairs visible
on the CTs were numbered and scored for each generation as normal or as BE
where the AA-ratio was >1.
Results: No signiﬁcant differences in incidence of BE were observed between the
2 cohorts studied. From CF-CT scoring: 1st CT, BE was present in 11 patients
(55%), compared to 13 patients (65%) at follow up CT. AA>1: 1st CT BE was
present in 3 patients (15%), compared to 10 patients (50%) at the follow up CT.
Conclusion: This study supports the progressive nature of BE and prevalence
of BE in young children, as observed in previous studies. The AA-ratio method
underestimates the prevalence of BE relative to CF-CT scoring method in children
age 2−3 years. We speculate that CF-CT scoring more readily detects abnormal
airways which are often not accompanied by visible arteries and thus not included
in the AA analysis.
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Background: Early histopathological studies on lung specimens from patients with
cystic ﬁbrosis (CF) and recent results from a mouse model indicate that emphysema
may contribute to CF lung disease. However, little is known about the relevance of
emphysema in patients with CF. In the present study, we used computationally generated
density masks based on multidetector computed tomography (MDCT) of the chest for
non-invasive characterization and quantiﬁcation of emphysema in CF.
Methods: Volumetric MDCT scans were acquired in parallel to pulmonary function
testing in 41 patients with CF and 21 non-CF controls, and subjected to dedicated
software. The lung was segmented, low attenuation volumes below a threshold of
−950 Hounsﬁeld units were assigned to emphysema volume (EV), and the emphysema
index (EI) was computed. Results were correlated with forced expiratory volume
in 1 s percent predicted (FEV1%), residual volume (RV), and RV/total lung capacity
(RV/TLC).
Results: We show that EV was increased in CF (457±530ml) compared to non-CF
controls (78±90 ml) (P < 0.01). EI was also increased in CF (7.7±7.5%) compared
to the control group (1.2±1.4%) (P < 0.05). EI correlated inversely with FEV1%
(rs = −0.66), and directly with RV (rs = 0.69) and RV/TLC (rs = 0.47) in patients
with CF (P < 0.007), but not in non-CF controls. Emphysema in CF was detected
from early adolescence (~13 years) and increased with age (rs = 0.67, P < 0.001).
Conclusions: Our results indicate that early onset emphysema detected by densitometry
on chest MDCT is a characteristic pathology that contributes to airﬂow limitation and
may serve as a novel therapeutic target in advanced CF.
